Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults.

KDOQI; National Kidney Foundation.

Am J Kidney Dis. 2006 May;47(5 Suppl 3):S16-85. No abstract available.

PMID:
16678661
[PubMed - indexed for MEDLINE]
2.

III. Clinical practice recommendations for anemia in chronic kidney disease in children.

KDOQI; National Kidney Foundation.

Am J Kidney Dis. 2006 May;47(5 Suppl 3):S86-108. No abstract available.

PMID:
16678669
[PubMed - indexed for MEDLINE]
3.

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

Locatelli F, Aljama P, Bárány P, Canaud B, Carrera F, Eckardt KU, Hörl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S; European Best Practice Guidelines Working Group.

Nephrol Dial Transplant. 2004 May;19 Suppl 2:ii1-47. No abstract available.

PMID:
15206425
[PubMed - indexed for MEDLINE]
Free Article
4.

International treatment guidelines for anaemia in chronic kidney disease - what has changed?

Macginley RJ, Walker RG.

Med J Aust. 2013 Jul 22;199(2):84-5. No abstract available.

PMID:
23879487
[PubMed - indexed for MEDLINE]
5.

Anemia in children with chronic kidney disease.

Koshy SM, Geary DF.

Pediatr Nephrol. 2008 Feb;23(2):209-19. Epub 2007 Jan 24. Review.

PMID:
17245602
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin.

Jones-Lecointe A, Green PJ, Lee HA.

Clin Lab Haematol. 1991;13(3):251-3.

PMID:
1794227
[PubMed - indexed for MEDLINE]
7.

[Treatment of anemia in chronically dialyzed patients].

Moynot A.

Nephrologie. 1998;19(3):125-7. Review. French. No abstract available.

PMID:
9633055
[PubMed - indexed for MEDLINE]
8.

[Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].

Fernández-Gallego J, Martín MA, Alonso A, Toledo R.

Nefrologia. 2006;26(1):143-4. Spanish. No abstract available.

PMID:
16649439
[PubMed - indexed for MEDLINE]
Free Article
9.

Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.

Kotaki M, Uday K, Henriquez M, Blum S, Dave M.

Clin Nephrol. 1997 Jul;48(1):63-4. No abstract available.

PMID:
9247787
[PubMed - indexed for MEDLINE]
10.

Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease.

Grabe DW.

Am J Health Syst Pharm. 2007 Jul 1;64(13 Suppl 8):S8-14; quiz S23-5.

PMID:
17591995
[PubMed - indexed for MEDLINE]
11.

[Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].

Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.

Rev Med Chil. 1990 Jun;118(6):629-34. Spanish.

PMID:
1775783
[PubMed - indexed for MEDLINE]
12.

Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis.

Berns JS, Mosenkis A.

Hemodial Int. 2005 Jan;9(1):7-22. Review.

PMID:
16191049
[PubMed - indexed for MEDLINE]
13.

Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP).

Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R; ERA-EDTA ERBP Advisory Board.

Nephrol Dial Transplant. 2009 Feb;24(2):348-54. doi: 10.1093/ndt/gfn653. Epub 2008 Nov 26. No abstract available.

PMID:
19037082
[PubMed - indexed for MEDLINE]
Free Article
14.

The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.

Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G.

J Pak Med Assoc. 1998 May;48(5):127-31.

PMID:
9813972
[PubMed - indexed for MEDLINE]
15.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
[PubMed - indexed for MEDLINE]
16.

[Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].

Sulková S, Kvasnicka J, Kasl M, Kozlová J, Podrouzek P, Bartůnková J, Válek A.

Cas Lek Cesk. 1989 Sep 29;128(40):1257-60. Czech.

PMID:
2582471
[PubMed - indexed for MEDLINE]
17.

Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.

Ramírez B, Flores A, Pérez F, Córdoba C, García L, Vázquez G.

Transplant Proc. 1991 Apr;23(2):1833-4. No abstract available.

PMID:
2053170
[PubMed - indexed for MEDLINE]
18.

Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.

Garcia-Canton C, Palomar R, Moreno A, Toledo A, Suria S, Esparza N, Rossique P, Checa MD.

Nephron. 1996;74(2):444-5. No abstract available.

PMID:
8893180
[PubMed - indexed for MEDLINE]
19.

How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: Adjuvant therapies to reduce erythropoiesis-stimulating agent dose requirements.

Shah HH, Fishbane SN.

Semin Dial. 2013 Sep-Oct;26(5):543-5. doi: 10.1111/sdi.12108. Epub 2013 Jun 14. Review. No abstract available.

PMID:
23763709
[PubMed - indexed for MEDLINE]
20.

[Stability of hemoglobin levels: an indispensible paradigm change in medical management].

Zaoui P, Deray G, Ortiz JP, Rostaing L.

Nephrol Ther. 2011 Feb;7(1 Suppl 2):H5-7. doi: 10.1016/S1769-7255(11)70002-5. Review. French. No abstract available.

PMID:
21371678
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk